Holen Sie sich die Stockscreener-App
26.98
1.70%
0.45
Schlusskurs vom Vortag:
$26.53
Offen:
$26.48
24-Stunden-Volumen:
5.23M
Relative Volume:
0.93
Marktkapitalisierung:
$3.03B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-99.15M
KGV:
-29.01
EPS:
-0.93
Netto-Cashflow:
$-74.25M
1W Leistung:
-0.26%
1M Leistung:
-20.72%
6M Leistung:
-3.44%
1J Leistung:
-51.29%
1-Tages-Spanne:
$25.77
$27.29
1-Wochen-Bereich:
$25.77
$28.26
52-Wochen-Spanne:
$18.92
$81.73
Viking Therapeutics Inc Stock (VKTX) Company Profile
Firmenname
Viking Therapeutics Inc
Sektor
Branche
Telefon
858-704-4660
Adresse
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Vergleichen Sie VKTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
26.98 | 2.98B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Goldman | Neutral |
| 2025-02-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-07 | Eingeleitet | Citigroup | Neutral |
| 2024-12-02 | Eingeleitet | Piper Sandler | Overweight |
| 2024-11-22 | Eingeleitet | B. Riley Securities | Buy |
| 2024-11-04 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-11 | Eingeleitet | JP Morgan | Overweight |
| 2024-06-27 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | Bestätigt | Oppenheimer | Outperform |
| 2024-03-07 | Eingeleitet | Jefferies | Buy |
| 2024-02-28 | Bestätigt | Oppenheimer | Outperform |
| 2023-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2023-03-28 | Bestätigt | Maxim Group | Buy |
| 2023-03-17 | Eingeleitet | Stifel | Buy |
| 2021-07-29 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-05-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-05-01 | Eingeleitet | BTIG Research | Buy |
| 2019-07-16 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-25 | Eingeleitet | Stifel | Buy |
| 2019-03-29 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | Bestätigt | Maxim Group | Buy |
| 2019-02-22 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Buy |
| 2018-11-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-18 | Bestätigt | Maxim Group | Buy |
| 2018-09-18 | Bestätigt | Raymond James | Outperform |
| 2018-07-20 | Eingeleitet | SunTrust | Buy |
| 2018-06-28 | Eingeleitet | Raymond James | Outperform |
| 2018-06-01 | Bestätigt | Laidlaw | Buy |
| 2018-05-31 | Bestätigt | Maxim Group | Buy |
| 2018-03-26 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-11-28 | Bestätigt | Maxim Group | Buy |
| 2017-11-21 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
Trend analysis for Viking Therapeutics Inc. this week2025 Major Catalysts & Target Return Focused Picks - Newser
When is the best time to exit Viking Therapeutics Inc.2025 Volatility Report & Stock Portfolio Risk Control - Newser
Can swing trading help recover from Viking Therapeutics Inc. lossesM&A Rumor & Daily Stock Trend Reports - Newser
Can Viking Therapeutics Inc. withstand a market correctionQuarterly Earnings Summary & Weekly Hot Stock Watchlists - خودرو بانک
Is Viking Therapeutics Inc. stock heavily shortedEarnings Beat & Daily Price Action Insights - خودرو بانک
Can Viking Therapeutics Inc. outperform in the next rallyQuarterly Investment Review & AI Based Buy and Sell Signals - خودرو بانک
Why Viking Therapeutics Inc. is moving today2025 Market Outlook & High Conviction Buy Zone Alerts - Newser
Will Viking Therapeutics Inc. benefit from macro trends2025 Risk Factors & Expert Approved Trade Ideas - Newser
Market reaction to Viking Therapeutics Inc.’s recent newsMarket Volume Report & Detailed Earnings Play Strategies - Newser
Is Viking Therapeutics Inc. exposed to political riskLayoff News & Fast Exit and Entry Trade Guides - خودرو بانک
Institutional scanner results for Viking Therapeutics Inc.Market Risk Report & Reliable Trade Execution Plans - Newser
Jim Cramer Expects Palantir To Reach New All-Time High - Benzinga
Forecasting Viking Therapeutics Inc. price range with options dataJuly 2025 Opening Moves & Technical Pattern Alert System - Newser
Exit strategy if you’re trapped in Viking Therapeutics Inc.Swing Trade & Community Trade Idea Sharing - Newser
Is Viking Therapeutics Inc. stock entering bullish territory2025 Valuation Update & AI Powered Market Trend Analysis - Newser
Down 34%, Should You Buy the Dip on Viking Therapeutics? - AOL.com
Published on: 2025-09-05 06:53:36 - Newser
Quantitative breakdown of Viking Therapeutics Inc. recent moveJuly 2025 Selloffs & Smart Investment Allocation Insights - Newser
Why Viking Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 PostEarnings & Real-Time Volume Trigger Notifications - Newser
Cramer's Market Picks: Palantir to $200, Viking Therapeutics a No-Go - AInvest
Viking Therapeutics Rises as Phase 3 Trials and Oral Formulation Progress Accelerate - MSN
What is Viking Therapeutics Inc. s P E ratio telling usShort Setup & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years - AOL.com
Using data filters to optimize entry into Viking Therapeutics Inc.July 2025 Decliners & Fast Gaining Stock Strategy Reports - Newser
Portfolio Update: Does Viking Therapeutics Inc. stock reflect fundamentals2025 Earnings Surprises & Safe Swing Trade Setups - khodrobank.com
What MACD signals say about Viking Therapeutics Inc.July 2025 Technicals & Verified Momentum Stock Watchlist - Newser
Price momentum metrics for Viking Therapeutics Inc. explained2025 Big Picture & Entry and Exit Point Strategies - Newser
Visual analytics tools that track Viking Therapeutics Inc. performance2025 Buyback Activity & Free Long-Term Investment Growth Plans - Newser
How to monitor Viking Therapeutics Inc. with trend dashboardsEntry Point & Fast Moving Market Watchlists - Newser
Published on: 2025-09-03 00:51:15 - Newser
Analyzing drawdowns of Viking Therapeutics Inc. with statistical toolsSell Signal & Reliable Price Action Trade Plans - Newser
What’s the recovery path for long term holders of Viking Therapeutics Inc.M&A Rumor & Community Trade Idea Sharing Platform - Newser
Does Viking Therapeutics Inc. stock reflect fundamentalsJuly 2025 Short Interest & Low Drawdown Trading Techniques - خودرو بانک
How to interpret RSI for Viking Therapeutics Inc. stockQuarterly Earnings Report & Long-Term Capital Growth Strategies - Newser
Can a trend reversal in Viking Therapeutics Inc. lead to recoveryWeekly Trade Summary & Detailed Earnings Play Strategies - Newser
Is Viking Therapeutics Inc. Forming a Bottom Pattern getLinesFromResByArray error: size == 0 - thegnnews.com
Applying big data sentiment scoring on Viking Therapeutics Inc.2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - Newser
How to use Fibonacci retracement on Viking Therapeutics Inc.Day Trade & Free Community Consensus Stock Picks - Newser
Viking Therapeutics Loses 20% in a Month: How to Play the Stock - sharewise.com
Real time social sentiment graph for Viking Therapeutics Inc.2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
Is Viking Therapeutics Inc. stock ready for a breakoutJuly 2025 WrapUp & Fast Gain Swing Alerts - Newser
Using AI based signals to follow Viking Therapeutics Inc.2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
Can Viking Therapeutics Inc. ride the EV waveJuly 2025 Final Week & Consistent Profit Trade Alerts - خودرو بانک
What MACD and RSI say about Viking Therapeutics Inc.July 2025 Opening Moves & AI Based Buy/Sell Signal Reports - Newser
Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):